Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Habashy, H.O., Powe, D.G., Staka, C.M., Rakha, E.A., Ball, G. ORCID: 0000-0001-5828-7129, Green, A.R., Aleskandarany, M., Paish, E.C., Macmillan, R.D., Nicholson, R.I., Ellis, I.O. and Gee, J.M.W., 2010. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment, 119 (2), pp. 283-293. ISSN 0167-6806

Full text not available from this repository.
Item Type: Journal article
Publication Title: Breast Cancer Research and Treatment
Creators: Habashy, H.O., Powe, D.G., Staka, C.M., Rakha, E.A., Ball, G., Green, A.R., Aleskandarany, M., Paish, E.C., Macmillan, R.D., Nicholson, R.I., Ellis, I.O. and Gee, J.M.W.
Date: 2010
Volume: 119
Number: 2
ISSN: 0167-6806
Identifiers:
NumberType
10.1007/s10549-009-0345-xDOI
Divisions: Schools > School of Science and Technology
Depositing User: EPrints Services
Date Added: 09 Oct 2015 10:26
Last Modified: 09 Jun 2017 13:30
URI: http://irep.ntu.ac.uk/id/eprint/13003

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year